Although ACE2 enables virus entry into host target cells, ACE2 upregulation induced by GLP-1 Ra may, in turn, lead to a paradoxically favourable effect and ameliorate lung injury during COVID-19 [14,45,46,51]. The gene discussed is GLP1R; the disease is COVID-19.